Brain Gene Silencing with Cationic Amino-Capped Poly(ethylene glycol) Polyplexes

Area of Science:

• Biotechnology
• Neuroscience
• Drug Delivery

Background:

• Therapeutic gene silencing in the brain typically requires invasive methods and can involve toxic vectors.
• Developing non-invasive and biocompatible delivery systems is crucial for brain gene therapy.

Purpose of the Study:

• To evaluate the efficacy and safety of using intranasal administration of siRNA complexed with poly(ethylene glycol) star-shaped polymer capped with amine groups (4APPA) for brain gene silencing.
• To assess the potential of this non-invasive delivery system for targeting the ITCH gene in the brain.

Main Methods:

• siRNA targeting the anti-itch E3 ubiquitin protein ligase (anti-ITCH) was complexed with 4APPA to form nanoparticles.
• Nanoparticle toxicity was assessed in A431 cells, and cellular uptake was confirmed using FACS and CLSM.
• Gene silencing was evaluated in vitro and in vivo in a rat model following intranasal administration.

Main Results:

• siRNA-4APPA polyplexes showed significantly lower toxicity compared to Lipofectamine 2000.
• Intranasal delivery resulted in nanoparticle distribution within key brain regions like the olfactory bulb, cerebral cortex, and mid-brain.
• Significant in vitro gene silencing (65% ITCH downregulation) and in vivo ITCH gene downregulation (54% remaining) were achieved in rat brains.

Conclusions:

• Intranasal administration of siRNA-4APPA polyplexes represents a promising, biocompatible, and non-invasive strategy for achieving therapeutic gene silencing in the brain.
• This method offers a safer alternative to conventional intracranial delivery systems for neurological gene therapies.